The Gut-Brain Axis — How Stress and Anxiety Affect IBS
IBS is now formally classified as a disorder of gut-brain interaction — a designation that reflects decades of research establishing the central role of the two-way communication system between the gut and the brain. This is not a concession that IBS is psychological; it is a recognition that the gut and brain are so deeply connected that the condition cannot be understood, or effectively managed, by treating either in isolation. This article explains the science behind that connection and what it means practically for people living with IBS.
What is the Gut-Brain Axis?
The gut-brain axis is the bidirectional communication network connecting the central nervous system (brain and spinal cord) with the enteric nervous system — the gut's own independent nervous system, sometimes called the "second brain." This network operates through multiple parallel channels simultaneously:
| Communication channel | Direction | What it carries |
|---|---|---|
| Vagus nerve | Primarily gut → brain (80–90% of fibres) | Gut state information: motility, distension, microbiome signals |
| HPA axis | Brain → gut | Stress hormones (cortisol, CRF) that alter gut motility and permeability |
| Enteric nervous system | Within the gut (semi-autonomous) | Local gut reflexes, motility control, secretion |
| Immune system | Bidirectional | Inflammatory signals; mast cell activation in gut mucosa |
| Gut microbiome | Gut → brain (via vagus, immune and metabolite signalling) | Short-chain fatty acids, neurotransmitter precursors, GABA signals |
The enteric nervous system contains approximately 500 million neurons — more than the spinal cord — and governs gut motility, secretion and blood flow largely independently. However, it is in constant dialogue with the central nervous system, and disruption to that dialogue is a defining feature of IBS.
Serotonin — The Gut's Key Signalling Molecule
Approximately 95% of the body's serotonin is produced in the gut, not the brain. In the gut, serotonin (5-hydroxytryptamine, or 5-HT) acts as the primary signalling molecule coordinating motility, fluid secretion and pain perception along the intestinal wall.
In IBS, serotonin signalling is dysregulated in subtype-specific ways:
| IBS subtype | Serotonin pattern | Clinical effect |
|---|---|---|
| IBS-D (diarrhoea-predominant) | Excess mucosal serotonin; impaired reuptake | Accelerated motility, urgency, loose stool |
| IBS-C (constipation-predominant) | Reduced serotonin signalling | Slowed transit, bloating, hard stool |
| IBS-M (mixed) | Variable / fluctuating | Alternating symptoms |
This is why some IBS medications target the serotonin system directly — alosetron (a 5-HT3 antagonist) slows motility for IBS-D, while prucalopride (a 5-HT4 agonist) accelerates it for IBS-C. The serotonin system is also why SSRI antidepressants, which modulate serotonin reuptake, sometimes affect IBS symptoms as a secondary effect.
How Stress Affects the Gut
When the brain perceives a stressor — whether physical or psychological — it activates the hypothalamic-pituitary-adrenal (HPA) axis, releasing corticotropin-releasing factor (CRF) and ultimately cortisol. In the gut, CRF receptors mediate a cascade of effects:
| Effect of stress on the gut | Consequence for IBS |
|---|---|
| Increased colonic motility | Urgency, diarrhoea, cramping |
| Increased intestinal permeability ("leaky gut") | Allows bacterial products into the gut wall; drives low-grade inflammation |
| Amplified visceral pain sensitivity | Normal gut sensations (gas, movement) register as pain |
| Mast cell activation in gut mucosa | Local immune response; histamine release worsens permeability and pain |
| Altered gut microbiome composition | Reduction in beneficial bacteria; increased inflammatory species |
These are the mechanisms behind the familiar "butterflies in the stomach" response to acute stress — but in IBS, each of these effects is amplified and persists longer than in people without the condition. Chronic stress sustains all of them simultaneously, which is why ongoing psychological stress is such a potent driver of persistent IBS.
Anxiety, Depression and IBS
Anxiety and depression are significantly more prevalent in people with IBS than in the general population — a finding consistent across studies worldwide. A systematic review found that anxiety was present in approximately 40% of IBS patients and depression in approximately 29%.
The relationship is not simple cause-and-effect in either direction. It is circular and self-reinforcing:
- Gut symptoms cause psychological distress — living with unpredictable, painful, socially inconvenient symptoms is inherently stressful
- Psychological distress worsens gut symptoms — through the HPA axis and vagal mechanisms described above
- Both share underlying neurobiological features — altered serotonin signalling, HPA axis dysregulation and inflammatory tone are common to both anxiety/depression and IBS
Anticipatory anxiety and the IBS cycle
A particularly clinically important pattern is anticipatory anxiety — worrying about having symptoms in a social or public situation, which itself activates the stress response and produces the symptoms being dreaded. This cycle is one of the mechanisms by which IBS progressively restricts daily life when left unaddressed. Identifying and breaking this cycle is a specific target of cognitive behavioural therapy for IBS.
Psychological Therapies with Evidence for IBS
Several psychological approaches have been shown in randomised controlled trials to reduce IBS symptom severity. These are not alternative treatments — they are evidence-based interventions that work through the gut-brain axis:
| Therapy | Evidence level | How it works for IBS | Availability in Ireland |
|---|---|---|---|
| Cognitive Behavioural Therapy (CBT) | Strong — multiple RCTs | Targets catastrophising, avoidance behaviour and the anticipatory anxiety cycle | Private clinical psychologists; limited HSE access |
| Gut-directed hypnotherapy | Strong — including long-term follow-up data | Reduces visceral hypersensitivity; normalises gut-brain communication via suggestion and visualisation | Private therapists trained in the Manchester protocol |
| Mindfulness-Based Stress Reduction (MBSR) | Moderate — consistent but smaller effect sizes | Reduces stress reactivity; improves pain tolerance and quality of life | Community classes; online programmes widely available |
| Psychodynamic psychotherapy | Emerging — some RCT evidence | Addresses underlying emotional patterns that sustain the stress response | Private therapists |
Gut-directed hypnotherapy was developed at the University of Manchester and involves typically 12 sessions using visualisation and suggestion techniques targeted specifically at gut function rather than general relaxation. It has Level 1 evidence for IBS and is recommended in some national gastroenterology guidelines. For people whose IBS has a significant stress or anxiety component, it is worth exploring alongside dietary approaches.
Practical Steps to Support the Gut-Brain Axis
Beyond formal therapies, a number of practical strategies have evidence for modulating the gut-brain axis in everyday life:
| Strategy | Mechanism | Evidence |
|---|---|---|
| Regular physical exercise | Reduces cortisol; improves vagal tone; supports microbiome diversity | Consistent observational and RCT data for IBS symptom improvement |
| Consistent sleep schedule | Restores HPA axis regulation; reduces next-day gut sensitivity | Poor sleep consistently associated with worse IBS symptom scores |
| Diaphragmatic breathing | Activates the vagus nerve; shifts autonomic balance toward parasympathetic | Shown to reduce visceral pain and anxiety in IBS studies |
| Structured meal timing | Supports gut circadian rhythm; reduces anticipatory anxiety around eating | Consistent meal timing associated with reduced IBS symptom variability |
| Social connection | Reduces chronic stress load; buffers HPA axis reactivity | Social isolation is a significant predictor of IBS severity in longitudinal studies |
| Probiotic fermented foods | Supports microbiome diversity; microbiome signals influence vagal tone and brain function | Emerging evidence — see kefir and probiotics articles |
Frequently Asked Questions
The gut-brain axis is the bidirectional communication network between the central nervous system and the enteric nervous system (the gut's own neural network). It operates via the vagus nerve, the HPA axis, the immune system and the gut microbiome simultaneously. Disruption to this communication network is a defining feature of IBS, which is formally classified as a disorder of gut-brain interaction rather than a purely structural or purely psychological condition.
Stress is a significant trigger and aggravating factor rather than a sole cause. Psychological stress activates the HPA axis, which increases colonic motility, intestinal permeability and visceral pain sensitivity. In people with IBS, this response is amplified compared to those without the condition. Chronic stress can also alter gut microbiome composition in ways that sustain IBS symptoms beyond the stressor itself. Managing IBS triggers typically requires addressing stress alongside dietary factors.
Evidence suggests yes, in many cases. Studies of CBT and gut-directed hypnotherapy show significant reductions in IBS symptom severity alongside improvements in anxiety and quality of life. This reflects the bidirectional gut-brain axis — reducing the psychological load reduces the nervous system's amplification of gut signals. Not every person responds, but psychological therapies are among the most effective non-dietary interventions available for IBS.
Neither exclusively — IBS is a disorder of gut-brain interaction with genuine physiological and psychological components that reinforce each other. The gut symptoms involve real, measurable changes in motility, visceral sensitivity and microbiome composition. The psychological component reflects the same gut-brain communication system being disrupted in both directions simultaneously. Dismissing IBS as purely psychosomatic or purely physical both misrepresent what the research shows.
Around 95% of the body's serotonin is produced in the gut, where it coordinates motility, fluid secretion and pain signalling. In IBS, serotonin is dysregulated in subtype-specific ways — excess serotonin signalling in IBS-D accelerates motility and causes urgency; reduced signalling in IBS-C slows transit. This is why medications targeting serotonin receptors (such as alosetron for IBS-D) are used in treatment, and why SSRIs sometimes affect gut symptoms as a secondary effect.
Gut-directed hypnotherapy is a specific form of clinical hypnotherapy developed at the University of Manchester, targeting gut hypersensitivity and gut-brain communication rather than general relaxation. It involves typically 12 sessions using visualisation and suggestion techniques focused on gut function. It has strong randomised controlled trial evidence for IBS efficacy, including long-term follow-up data showing sustained benefit, and is recommended in some national gastroenterology guidelines.
Yes. The gut microbiome communicates with the brain via the vagus nerve, immune signalling and the production of neuroactive compounds including short-chain fatty acids and serotonin precursors. Disruption to the microbiome through antibiotics, poor diet or infection is associated with changes in mood and anxiety. In IBS, microbiome alterations are consistently observed and may contribute to both gut and psychological symptoms simultaneously — which is one of the rationales for probiotic approaches in IBS management.
IBS.ie
Ireland's dedicated IBS information resource. We provide evidence-based, HSE and PubMed-referenced content on irritable bowel syndrome — covering symptoms, diet, gut health and management. All content is for general information only. Always consult your GP or a qualified specialist for personal medical advice.
Related Articles
Sources & References
Mayer, E.A., et al. (2015). Gut/Brain Axis and the Microbiota. Journal of Clinical Investigation. View on PubMed ↗
Gershon, M.D. (2012). Serotonin signalling in the gut. Neuropsychopharmacology. View on PubMed ↗
Fond, G., et al. (2014). Anxiety and depression in IBS: a systematic review. European Archives of Psychiatry and Clinical Neuroscience. View on PubMed ↗
Lackner, J.M., et al. (2018). Cognitive behaviour therapy for irritable bowel syndrome: the role of patient education and homework compliance. Behaviour Research and Therapy. View on PubMed ↗
HSE. Irritable Bowel Syndrome. View on HSE.ie ↗
